Bicycle Therapeutics Plc

Ownership Transactions Reported by 20 Insiders

Symbol: BCYC on Nasdaq
Industry: Pharmaceutical Preparations
Location: Blocks A & B, Portway Building, Granta Park, Great Abington, Cambridge, United Kingdom

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+1.49M	95.8%	$14.29	+$21.2M
Sells	9	-65.7K	4.2%	$17.73	-$1.16M
Net	-8	+1.42M	91.5%		+$20.1M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Baker Bros. Advisors Lp	Director, 10%+ Owner	$536M	+$21.2M	+4.13%	Jan 2, 2025
Kate Bingham	Director	$32.7M			Jul 13, 2021
Kevin Lee	CHIEF EXECUTIVE OFFICER, Director	$7.26M	-$382K	-5.01%	Jan 2, 2025
Gregory Paul Winter	Director	$4.64M			Jan 2, 2025
Michael Skynner	Chief Technology Officer	$1.82M	-$123K	-6.34%	Jan 2, 2025
Alistair Milnes	Chief Operating Officer	$1.47M	-$142K	-8.78%	Jan 2, 2025
Nicholas Keen	Chief Scientific Officer	$1.36M	-$34.1K	-2.45%	Jul 3, 2024
Santiago Arroyo	Chief Development Officer	$973K	-$69.6K	-6.68%	Jan 2, 2025
Michael Charles Ferguson Hannay	Chief Prod & Supply Chain Off	$815K	-$46.1K	-5.35%	Jan 2, 2025
Nigel Crockett	Chief Business Officer	$753K	-$114K	-13.1%	Jan 2, 2025
Pierre Legault	Director	$690K			Jan 2, 2025
Alethia Young	Chief Financial Officer	$643K	-$19.7K	-2.97%	Jan 2, 2025
Dominic Smethurst	Chief Medical Officer	$642K			Jan 3, 2023
Jose-Carlos Gutierrez-Ramos	Director	$571K			Jan 2, 2025
Janice Bourque	Director	$571K			Jan 2, 2025
Richard N. Kender	Director	$571K			Jan 2, 2025
Lee Kalowski	President and CFO	$530K			Apr 3, 2023
Travis Alvin Thompson	Chief Accounting Officer	$482K	-$234K	-32.7%	Jan 2, 2025
Stephen H. Sands	Director	$432K			Jan 2, 2025
Veronica GH Jordan	Director	$293K			Jan 2, 2024

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.